Source: iQoncept / Shutterstock
IO Biotech (NASDAQ:IOBT) recently unveiled its financial performance for the final quarter of 2023.
- Surprisingly, IO Biotech posted earnings per share of -40 cents, slipping below the market projections of -39 cents.
- In a twist of fate, the company refrained from disclosing any revenue figures for the quarter, keeping investors on their toes.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/iobt-stock-earnings-io-biotech-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC